0001209191-21-050055.txt : 20210805
0001209191-21-050055.hdr.sgml : 20210805
20210805193409
ACCESSION NUMBER: 0001209191-21-050055
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210803
FILED AS OF DATE: 20210805
DATE AS OF CHANGE: 20210805
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fisher Stewart
CENTRAL INDEX KEY: 0001824863
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39567
FILM NUMBER: 211150151
MAIL ADDRESS:
STREET 1: C4 THERAPEUTICS, INC.
STREET 2: 490 ARSENAL WAY, SUITE 200
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: C4 Therapeutics, Inc.
CENTRAL INDEX KEY: 0001662579
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 475617627
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 ARSENAL WAY
STREET 2: SUITE 200
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: (617) 231-0700
MAIL ADDRESS:
STREET 1: 490 ARSENAL WAY
STREET 2: SUITE 200
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-08-03
0
0001662579
C4 Therapeutics, Inc.
CCCC
0001824863
Fisher Stewart
C/O C4 THERAPEUTICS, INC.
490 ARSENAL WAY #200
WATERTOWN
MA
02472
0
1
0
0
Chief Scientific Officer
Common Stock
2021-08-03
4
S
0
17057
45.0145
D
22744
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2021.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.10. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
/s/ Shoaib Ghias, Attorney-in-Fact
2021-08-05